Atlas Trials

Human Metapneumovirus Vaccination

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Human Metapneumovirus Vaccination

RecordFirmDate
A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age. (NCT06850051)Sanofi2025-03-19

Track Human Metapneumovirus Vaccination automatically

Every clearance here is in the API, with alerts when new ones post.